The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero. Currently, India imp...

The govt may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notificati...

The drug regulator had earlier this year formed an expert panel to evaluate medicines which can become OTC from prescription after pharmace...

In a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...

"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...

The pharmaceutical industry has sought an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit. In a meeting he...

In this regard, the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA) have invited members of ph...

India is trying to encourage local manufacture of APIs, intermediates and key starting material used in the production of drugs and cut dep...

The DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” com...

Telangana industries minister KT Rama Rao pointed out that the pharma industry’s growth rate fell to 5.5% in the past two years while the c...

In the recent past, much of adverse propaganda is taking place against the Indian companies with an intention to malign the image of Indian...

The Pharmaceuticals Export Council of India (Pharmexcil) set up by the Ministry of Commerce and Industry under foreign trade policy on Thur...

Druker welcomed the ruling but with a caveat: the price of medications should not be restricted to the extent that it inhibits future inves...

Indian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minist...

The change of heart comes ahead of the release of a report by the panel set up to study a proposal to reduce the FDI in pharma sector from ...

Indian govt and a handful of private entities have spent over $10 mn on lobbying activities in the power corridors. Indian ADRs gain $7 bn;...

Reliance Industries, Nasscom, Sun Pharma and Orchid Chemicals -- have together paid close to $2,75,000 (about Rs 1.4 crore) towards lobbyin...